Insight Molecular Diagnostics (IMDX) Profit After Tax (2015 - 2026)
Insight Molecular Diagnostics (IMDX) posted Profit After Tax of -$4.3 million for Q1 2026, up 81.31% sequentially from -$23.0 million in Q4 2025, and up 35.69% YoY from -$3.2 million in Q1 2025.
Insight Molecular Diagnostics (IMDX) Profit After Tax (2015 - 2026) Analysis & Trends
Insight Molecular Diagnostics has reported Profit After Tax for 12 years, with the latest figure at -$4.3 million in Q1 2026.
- Quarterly Profit After Tax rose 35.69% year-over-year to -$4.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$47.8 million (up 18.18% YoY) and the FY2025 annual result came in at -$50.2 million, up 17.57% from the prior year.
- Profit After Tax advanced to -$4.3 million in Q1 2026 per IMDX's latest filing, from -$23.0 million in the prior quarter.
- Over five years, Profit After Tax peaked at $6.0 million in Q1 2023 and troughed at -$44.7 million in Q4 2022.
- A 5-year average of -$12.5 million and a median of -$9.6 million in 2022 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2023 and 2024: Profit After Tax surged 157.9% in 2023, then slumped 253.2% in 2024.
- Over 5 years, Profit After Tax stood at -$44.7 million in 2022, then jumped by 64.21% to -$16.0 million in 2023, then slumped by 111.19% to -$33.8 million in 2024, then soared by 32.03% to -$23.0 million in 2025, then jumped by 81.31% to -$4.3 million in 2026.
- According to Business Quant data, Profit After Tax over the past three periods registered -$4.3 million, -$23.0 million, and -$10.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 1.74 Bn |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 338.41 Mn |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | 258.00 Mn |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | -85.09 Mn |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 256.84 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 334.00 Mn |
| 10 | Insight Molecular Diagnostics | 172.94 Mn | 144.01 Mn | 15,000.00 | -4.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.29 Mn |
| Dec 31, 2025 | -22.96 Mn |
| Sep 30, 2025 | -10.85 Mn |
| Jun 30, 2025 | -9.74 Mn |
| Mar 31, 2025 | -6.67 Mn |
| Dec 31, 2024 | -33.77 Mn |
| Sep 30, 2024 | -13.49 Mn |
| Jun 30, 2024 | -4.53 Mn |
| Mar 31, 2024 | -9.13 Mn |
| Dec 31, 2023 | -15.99 Mn |
| Sep 30, 2023 | -6.49 Mn |
| Jun 30, 2023 | -8.33 Mn |
| Mar 31, 2023 | 5.96 Mn |
| Dec 31, 2022 | -44.68 Mn |
| Sep 30, 2022 | -9.63 Mn |
| Jun 30, 2022 | -8.30 Mn |
| Mar 31, 2022 | -10.29 Mn |
| Dec 31, 2021 | -35.89 Mn |
| Sep 30, 2021 | -13.80 Mn |
| Jun 30, 2021 | -10.49 Mn |